Fernando Albericio holds a Ph.D. in Chemistry from the University of Barcelona (1980). Following postdoctoral work (1981-1984) at Tufts University, the Université d’Aix-Marseille, and the University of Minnesota, he was appointed Associate Professor at the University of Barcelona. After a few years, he took up the position of Director of Peptide Research at Milligen-Biosearch, Boston, USA (1992-1994), and then re-joined the University of Barcelona in 1995, when he was promoted to Full Professor. He also served as Executive Director of the Barcelona Science Park (2005-2011).
His major research interests cover practically all aspects of peptide synthesis and combinatorial chemistry methodology, as well as the synthesis of peptides and small molecules with therapeutic activity. His group is also involved in the development of new strategies for drug delivery. He has published over 650 papers, several review articles, and 42 patents, and has co-authored three books.
He is currently Editor of the International Journal of Peptide Research and Therapeutics and a Councillor of the American Peptide Society. Recently, he has been honoured with a Doctorate Honoris Causa by the Universidad de Buenos Aires (Argentina) and the Vincent du Vigneaud award by the American Peptide Society.
He is deeply involved in the development of the third mission of the university, namely the transferral of knowledge and technology to society. He has founded several biotech companies and he serves on the board of directors of various foundations and companies. Furthermore, he is a consultant for a number of companies operating in the chemical, pharmaceutical, and cosmetic sectors.